Zurich Cantonal Bank
PCRX icon

Zurich Cantonal Bank’s Pacira BioSciences PCRX Stock Holding History

Zurich Cantonal Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Hold
8,982
– – ﹤0.01% 2283
2026
Q1 		$203K Buy
+8,982
New +$200K ﹤0.01% 2241
2025
Q4 		– Sell
-16,255
Closed -$387K – 3243
2025
Q3 		$419K Sell
16,255
-195
-1% -$4.79K ﹤0.01% 1841
2025
Q2 		$393K Sell
16,450
-69
-0.4% -$1.74K ﹤0.01% 1800
2025
Q1 		$410K Buy
16,519
+2,848
+21% +$68.2K ﹤0.01% 1716
2024
Q4 		$258K Buy
13,671
+2,725
+25% +$47.8K ﹤0.01% 2039
2024
Q3 		$165K Sell
10,946
-72
-0.7% -$1.23K ﹤0.01% 2216
2024
Q2 		$315K Buy
11,018
+31
+0.3% +$882 ﹤0.01% 1800
2024
Q1 		$321K Buy
10,987
+15
+0.1% +$461 ﹤0.01% 1771
2023
Q4 		$370K Buy
10,972
+26
+0.2% +$761 ﹤0.01% 1706
2023
Q3 		$336K Buy
10,946
+2,764
+34% +$99.6K ﹤0.01% 1638
2023
Q2 		$328K Hold
8,182
– – ﹤0.01% 1618
2023
Q1 		$334K Buy
8,182
+839
+11% +$33.4K ﹤0.01% 1546
2022
Q4 		$284K Buy
7,343
+582
+9% +$28.3K ﹤0.01% 1606
2022
Q3 		$360K Hold
6,761
– – ﹤0.01% 1392
2022
Q2 		$394K Sell
6,761
-39
-0.6% -$2.56K ﹤0.01% 1369
2022
Q1 		$519K Buy
6,800
+520
+8% +$34.7K ﹤0.01% 1311
2021
Q4 		$378K Buy
6,280
+2,302
+58% +$127K ﹤0.01% 1657
2021
Q3 		$223K Hold
3,978
– – ﹤0.01% 1854
2021
Q2 		$241K Hold
3,978
– – ﹤0.01% 1696
2021
Q1 		$279K Sell
3,978
-1,566
-28% -$112K ﹤0.01% 1588
2020
Q4 		$332K Hold
5,544
– – ﹤0.01% 1525
2020
Q3 		$333K Hold
5,544
– – ﹤0.01% 1284
2020
Q2 		$291K Buy
5,544
+754
+16% +$31.5K ﹤0.01% 1293
2020
Q1 		$161K Buy
4,790
+2,428
+103% +$101K ﹤0.01% 1327
2019
Q4 		$107K Hold
2,362
– – ﹤0.01% 1683
2019
Q3 		$90K Hold
2,362
– – ﹤0.01% 1669
2019
Q2 		$103K Hold
2,362
– – ﹤0.01% 1609
2019
Q1 		$90K Sell
2,362
-588
-20% -$22.9K ﹤0.01% 1641
2018
Q4 		$127K Buy
2,950
+538
+22% +$25.1K ﹤0.01% 1455
2018
Q3 		$119K Buy
2,412
+428
+22% +$18.5K ﹤0.01% 1615
2018
Q2 		$64K Hold
1,984
– – ﹤0.01% 1964
2018
Q1 		$62K Hold
1,984
– – ﹤0.01% 1910
2017
Q4 		$91K Buy
1,984
+516
+35% +$20.4K ﹤0.01% 1625
2017
Q3 		$55K Hold
1,468
– – ﹤0.01% 1743
2017
Q2 		$70K Buy
1,468
+211
+17% +$9.79K ﹤0.01% 1564
2017
Q1 		$57K Hold
1,257
– – ﹤0.01% 1669
2016
Q4 		$41K Hold
1,257
– – ﹤0.01% 1825
2016
Q3 		$43K Buy
1,257
+149
+13% +$5.84K ﹤0.01% 1736
2016
Q2 		$37K Hold
1,108
– – ﹤0.01% 1658
2016
Q1 		$59K Hold
1,108
– – ﹤0.01% 1369
2015
Q4 		$85K Buy
1,108
+742
+203% +$42K ﹤0.01% 1206
2015
Q3 		$15K Buy
366
+218
+147% +$13.4K ﹤0.01% 1642
2015
Q2 		$10K Hold
148
– – ﹤0.01% 1387
2015
Q1 		$13K Buy
+148
New +$15K ﹤0.01% 1247

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's PCRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 8,982 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Zurich Cantonal Bank first reported a position in PCRX in Q1 2015 and has held it in 45 quarters since. The position peaked at $519K in Q1 2022. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Zurich Cantonal Bank held 8,982 shares of Pacira BioSciences worth $228K as of Q2 2026.
  • Zurich Cantonal Bank left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2283 holding.
  • Zurich Cantonal Bank first reported a position in Pacira BioSciences in Q1 2015 and has held it in 45 quarters since.
  • Zurich Cantonal Bank's Pacira BioSciences position peaked at $519K in Q1 2022.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.